Treating a GAD65 Antibody-Associated Limbic Encephalitis with Basiliximab: A Case Study.

Front Neurol · 2015 · PMC4522569 · PMID 26284025

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

An increase might have been more effective, since the observed dramatic expansion of CD56 bright NK cells under Daclizumab hyp ( 23 ) could be observed here, but only a slight trend was visible (data not shown).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.